To further explore the possible biological mechanisms of LOXL1-AS1 in HCC pathogenesis, flow cytometry was used to validate the effect of LOXL1-AS1 silencing on cell cycle progression. The gene discussed is LOXL1; the disease is hepatocellular carcinoma.